Alfredo Adán Selected Research

tocilizumab (atlizumab)

1/2021	Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report.
10/2019	Cytokine production in thyroid eye disease: in vitro effects of dexamethasone and IL-6 blockade with tocilizumab.
1/2019	Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
1/2018	TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.
10/2017	Targeting interleukin-6 in autoimmune uveitis.
1/2017	Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
1/2017	In Response to: "Deuter CM, Zierhut M, Igney-Oertel A, et al. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment".
12/2016	Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
12/2014	Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.
1/2014	Tocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: a case report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfredo Adán Research Topics

Disease

32	Uveitis 11/2021 - 03/2009
21	Macular Edema 11/2021 - 01/2013
16	Inflammation (Inflammations) 01/2021 - 10/2010
7	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021 - 03/2009
5	Behcet Syndrome (Behcet's Syndrome) 01/2021 - 01/2013
4	Choroidal Neovascularization 02/2019 - 03/2003
3	Cataract (Cataracts) 11/2021 - 11/2008
3	Posterior Uveitis 12/2020 - 10/2010
3	Neoplasms (Cancer) 01/2020 - 01/2014
3	Rheumatoid Arthritis 01/2020 - 04/2013
3	Retinal Vasculitis 01/2018 - 10/2012
2	Psoriatic Arthritis 01/2020 - 04/2013
2	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 02/2011
2	Ankylosing Spondylitis 01/2020 - 04/2013
2	Panuveitis 01/2018 - 10/2012
2	Infections 10/2017 - 11/2008
2	Vasculitis (Vasculitides) 03/2017 - 10/2014
2	Birdshot Chorioretinopathy 01/2017 - 10/2011
2	Ischemia 01/2017 - 10/2003
2	Necrosis 04/2014 - 10/2013
1	Atrophy 01/2022
1	Arthritis (Polyarthritis) 11/2021
1	Susac Syndrome 11/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2021
1	COVID-19 01/2021
1	Immune System Diseases (Immune Disorders) 01/2020
1	Edema (Dropsy) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Multiple Sclerosis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Graves Ophthalmopathy 10/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2019
1	Vascular Diseases (Vascular Disease) 10/2019
1	Hemorrhage 02/2019
1	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 02/2019
1	Lymphoma (Lymphomas) 01/2019
1	Retinal Vein Occlusion 10/2017
1	Eye Diseases (Eye Disease) 10/2017
1	Chronic Disease (Chronic Diseases) 10/2017
1	Phlebitis 03/2017
1	Retinal Detachment (Retinal Detachments) 01/2017
1	Ocular Toxoplasmosis 10/2013

Drug/Important Bio-Agent (IBA)

12	tocilizumab (atlizumab)FDA Link 01/2021 - 09/2013
11	Retinaldehyde (Retinal)IBA 01/2022 - 10/2011
9	Adalimumab (Humira)FDA Link 11/2021 - 10/2012
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 06/2004
7	CytokinesIBA 09/2021 - 10/2013
7	Dexamethasone (Maxidex)FDA LinkGeneric 03/2021 - 07/2013
6	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2019 - 11/2013
6	Biological ProductsIBA 01/2019 - 04/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 03/2007
5	Infliximab (Remicade)FDA Link 01/2021 - 03/2007
5	Monoclonal AntibodiesIBA 10/2019 - 03/2007
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2013
4	C-Reactive ProteinIBA 01/2020 - 01/2014
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 12/2014
3	Pharmaceutical PreparationsIBA 01/2020 - 04/2014
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 01/2014
3	golimumab FDA Link 07/2018 - 04/2013
3	Biomarkers (Surrogate Marker)IBA 03/2017 - 06/2014
3	Fluorescein (Funduscein)FDA LinkGeneric 10/2014 - 03/2003
3	InterferonsIBA 04/2014 - 10/2013
2	Fluocinolone Acetonide (Capex)FDA LinkGeneric 11/2021 - 01/2020
2	Antinuclear AntibodiesIBA 11/2021 - 06/2014
2	Certolizumab Pegol FDA Link 01/2021 - 01/2016
2	InterleukinsIBA 01/2020 - 10/2013
2	Interleukin-2 (IL2)IBA 10/2013 - 05/2013
2	Bevacizumab (Avastin)FDA Link 12/2007 - 11/2007
1	anti-dsDNA autoantibodyIBA 11/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2021
1	N-acetyltryptophanamide (NATA)IBA 09/2020
1	Vascular Endothelial Growth FactorsIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2019
1	GlucocorticoidsIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 03/2017
1	HLA-DR alpha-ChainsIBA 01/2017
1	P-2 (P 2)IBA 01/2017
1	HLA-A Antigens (HLA-A)IBA 01/2017
1	HLA-DR15 antigenIBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 12/2016
1	Antirheumatic Agents (DMARD)IBA 12/2016
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2016
1	HLA-B51 AntigenIBA 12/2014
1	AntigensIBA 04/2014
1	HLA-B Antigens (HLA-B)IBA 04/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2013
1	Interleukin-10 (Interleukin 10)IBA 10/2013
1	Interleukin-8 (Interleukin 8)IBA 10/2013

Therapy/Procedure

15	Therapeutics 11/2021 - 02/2011
6	Vitrectomy 11/2021 - 03/2003
5	Biological Therapy 01/2021 - 09/2016
3	Injections 01/2021 - 02/2019
3	Intravitreal Injections 01/2020 - 12/2007
1	Aftercare (After-Treatment) 11/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Lasers (Laser) 10/2014
1	Immunomodulation 11/2013